Catalyst Capital Advisors’s Xylem XYL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q4
– Sell
-869
Closed -$128K – 464
2025
Q3
$128K Sell
869
-38
-4% -$5.27K ﹤0.01% 275
2025
Q2
$117K Buy
907
+380
+72% +$46K ﹤0.01% 309
2025
Q1
$63K Sell
527
-291
-36% -$36.1K ﹤0.01% 351
2024
Q4
$94.9K Buy
818
+479
+141% +$60.6K ﹤0.01% 302
2024
Q3
$45.8K Buy
339
+235
+226% +$31.4K ﹤0.01% 349
2024
Q2
$14.1K Sell
104
-13
-11% -$1.77K ﹤0.01% 362
2024
Q1
$15.1K Sell
117
-15
-11% -$1.81K ﹤0.01% 364
2023
Q4
$15.1K Sell
132
-28
-18% -$2.79K ﹤0.01% 331
2023
Q3
$14.6K Buy
+160
New +$16.5K ﹤0.01% 375
2015
Q4
– Sell
-10,000
Closed -$329K – 658
2015
Q3
$329K Buy
+10,000
New +$336K 0.04% 237

Other funds holding XYL

Catalyst Capital Advisors's XYL Position: Q4 2025 in Review

Catalyst Capital Advisors sold out of Xylem (XYL) in Q4 2025, closing a stake of 869 shares — an estimated $128K sold.

Catalyst Capital Advisors first reported a position in XYL in Q3 2015 and held it in 10 quarters. The position peaked at $329K in Q3 2015. 1,135 funds tracked by Wall St. Rank hold XYL as of Q4 2025.

  • Catalyst Capital Advisors reported no remaining Xylem position as of Q4 2025 after selling out during the quarter.
  • Catalyst Capital Advisors sold 869 Xylem shares in Q4 2025, an estimated $128K.
  • Catalyst Capital Advisors first reported a position in Xylem in Q3 2015 and held it in 10 quarters.
  • Catalyst Capital Advisors's Xylem position peaked at $329K in Q3 2015.
  • 1,135 funds tracked by Wall St. Rank held Xylem as of Q4 2025.

Based on Catalyst Capital Advisors's 13F filing for Q4 2025, filed 10 Feb 2026.